Albumin formulation and use
US10844349B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2012 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Jul 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/998
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to a new formulation of albumin, a method for producing the albumin formulation and to uses of the albumin formulation, for example in cell culture such as mammalian cell culture and particularly in stem cell culture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.